M. D. Creinin, Alicyoy Angulo, Enrico Colli, David F. Archer
{"title":"不含雌激素的口服避孕药屈螺酮 4 毫克（24/4 天疗法）对肥胖者的疗效、安全性和耐受性研究","authors":"M. D. Creinin, Alicyoy Angulo, Enrico Colli, David F. Archer","doi":"10.1097/01.ogx.0001016688.86364.3f","DOIUrl":null,"url":null,"abstract":"(Abstracted from Contraception 2023;128:1–7\n There is a lack of data regarding the safety and efficacy of oral contraceptives in people with a body mass index (BMI) over 35. Drospirenone 4 mg is a new progestogen-only contraceptive pill that is taken in a 24 + 4 pattern, with 24 hormonal and 4 placebo pills.","PeriodicalId":509854,"journal":{"name":"Obstetrical & Gynecological Survey","volume":"75 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Efficacy, Safety, and Tolerability of an Estrogen-Free Oral Contraceptive Drospirenone 4 mg (24/4-Day Regimen) in Obese Users\",\"authors\":\"M. D. Creinin, Alicyoy Angulo, Enrico Colli, David F. Archer\",\"doi\":\"10.1097/01.ogx.0001016688.86364.3f\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"(Abstracted from Contraception 2023;128:1–7\\n There is a lack of data regarding the safety and efficacy of oral contraceptives in people with a body mass index (BMI) over 35. Drospirenone 4 mg is a new progestogen-only contraceptive pill that is taken in a 24 + 4 pattern, with 24 hormonal and 4 placebo pills.\",\"PeriodicalId\":509854,\"journal\":{\"name\":\"Obstetrical & Gynecological Survey\",\"volume\":\"75 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Obstetrical & Gynecological Survey\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/01.ogx.0001016688.86364.3f\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obstetrical & Gynecological Survey","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.ogx.0001016688.86364.3f","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Efficacy, Safety, and Tolerability of an Estrogen-Free Oral Contraceptive Drospirenone 4 mg (24/4-Day Regimen) in Obese Users
(Abstracted from Contraception 2023;128:1–7
There is a lack of data regarding the safety and efficacy of oral contraceptives in people with a body mass index (BMI) over 35. Drospirenone 4 mg is a new progestogen-only contraceptive pill that is taken in a 24 + 4 pattern, with 24 hormonal and 4 placebo pills.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
